Deutsche Bank
HOWL icon

Deutsche Bank’s Werewolf Therapeutics HOWL Stock Holding History

Deutsche Bank’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-101,626
Closed -$98.6K – 3655
2025
Q1 		$98.6K Hold
101,626
– – ﹤0.01% 3197
2024
Q4 		$150K Buy
101,626
+83,172
+451% +$170K ﹤0.01% 3178
2024
Q3 		$39.1K Buy
+18,454
New +$42K ﹤0.01% 3400
2022
Q2 		– Sell
-14,349
Closed -$63K – 4209
2022
Q1 		$63K Sell
14,349
-1,698
-11% -$11.9K ﹤0.01% 3760
2021
Q4 		$191K Buy
16,047
+11,696
+269% +$177K ﹤0.01% 3410
2021
Q3 		$75K Sell
4,351
-141
-3% -$2.41K ﹤0.01% 4007
2021
Q2 		$78K Buy
+4,492
New +$61.5K ﹤0.01% 4213

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.49M AUM 18.57% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Deutsche Bank's HOWL Position: Q2 2025 in Review

Deutsche Bank sold out of Werewolf Therapeutics (HOWL) in Q2 2025, closing a stake of 101,626 shares — an estimated $98.6K sold.

Deutsche Bank first reported a position in HOWL in Q2 2021 and held it in 7 quarters. The position peaked at $191K in Q4 2021. 65 funds tracked by Wall St. Rank hold HOWL as of Q2 2025.

  • Deutsche Bank reported no remaining Werewolf Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Deutsche Bank sold 101,626 Werewolf Therapeutics shares in Q2 2025, an estimated $98.6K.
  • Deutsche Bank first reported a position in Werewolf Therapeutics in Q2 2021 and held it in 7 quarters.
  • Deutsche Bank's Werewolf Therapeutics position peaked at $191K in Q4 2021.
  • 65 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q2 2025.

Based on Deutsche Bank's 13F filing for Q2 2025, filed 12 Aug 2025.